Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cost of MRI screening for women with a family history of breast cancer

Dr Sepideh Saadatmand - Erasmus University Medical Center, Rotterdam, Netherlands
Cost of MRI screening for women with a family history of breast cancer ( Dr Sepideh Saadatmand - Erasmus University Medical Center, Rotterdam, Netherlands )
22 Mar 2012

Effectiveness of breast cancer screening

Rianne de Gelder - Erasmus University Medical Center, Rotterdam, Netherlands
Effectiveness of breast cancer screening ( Rianne de Gelder - Erasmus University Medical Center, Rotterdam, Netherlands )
22 Mar 2012

Results from national breast cancer screening programme

Jacques Fracheboud - Erasmus University Medical Center, Rotterdam, Netherlands
Results from national breast cancer screening programme ( Jacques Fracheboud - Erasmus University Medical Center, Rotterdam, Netherlands )
22 Mar 2012

Recent advances in multiple myeloma therapy

Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon
Recent advances in multiple myeloma therapy ( Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon )
14 Feb 2012

Recent advances in non-Hodgkin’s lymphoma therapy

Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter
Recent advances in non-Hodgkin’s lymphoma therapy ( Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter )
14 Feb 2012

The latest in prostate cancer imaging

Prof Anwar Padhani - Mount Vernon Cancer Institute, UK
The latest in prostate cancer imaging ( Prof Anwar Padhani - Mount Vernon Cancer Institute, UK )
3 Feb 2012

BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma

Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston
BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma ( Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston )
9 Jan 2012

Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS)

Dr Laurie Sehn - University of British Columbia, Vancouver, Canada
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )
9 Jan 2012

ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma

Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma ( Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group )
9 Jan 2012

Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT)

Prof Brad Kahl - University of Wisconsin, Madison, USA
Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT) ( Prof Brad Kahl - University of Wisconsin, Madison, USA )
9 Jan 2012

Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide

Prof Keith Stewart - Mayo Clinic, Scottsdale, USA
Cereblon expression required for anti-myeloma activity of lenalidomide and pomalidomide ( Prof Keith Stewart - Mayo Clinic, Scottsdale, USA )
9 Jan 2012

Tips and tricks in triple-negative breast cancer

Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium
Tips and tricks in triple-negative breast cancer ( Prof Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
9 Jan 2012